Phase 1 (1-3 months):
Whitepaper development, finalization of foundation legal structure, initial investor recruitment
09/22/2025
At the core of JMK's strategy is a targeted focus on partnerships and acquisitions with companies and research institutes that possess essential stem cell treatment technologies. Rather than investing in costly in-house culture facilities, JMK Token-backed initiatives focus on securing proprietary treatment protocols and clinical application technologies, ensuring faster scalability and reduced upfront infrastructure investment.
Know More
Always know the value. JMK tracks live prices across major DeFi platforms, so you’re always updated and in control. Live DEX & oracle integration Smart contract-backed accuracy Real-time data for smarter decisions
Affordable. Efficient. Inclusive. JMK is built to reduce gas fees and simplify access, making DeFi benefits available to everyone. Gas-efficient smart contracts Layer 2 / multichain support Minimal transaction fees
Nothing hidden. Everything recorded. Every action on JMK is on-chain and open-source ensuring full transparency and community trust. Auditable smart contracts DAO governance Open codebase
Get rewarded for living well. Earn JMK tokens by being active, contributing, or referring others. Health meets income. Rewards for health activities Staking, farming, and referrals Incentives for community growth
Your assets, fully protected. Security is built in from smart contracts to cold wallets, so you stay safe and in control. Multi-sig wallets, cold storage Security audits & encryption. No third-party risk
More ways to profit. From staking to referrals, JMK offers diverse ways to grow your earnings. Staking & liquidity mining, Health-based rewards, Referral and ambassador programs
Not just a token JMK is a movement for global health and shared wealth, backed by real-world impact and blockchain transparency.
Whitepaper development, finalization of foundation legal structure, initial investor recruitment
09/22/2025Coin issuance and private sale, design of first national center
11/22/2025Center construction commences (priority) (5 countries) Marketing commencement
05/22/2026Expansion to remaining countries in 1-2 years, contract or construction of a central cultivation facility
05/22/2027Completion of the global network in 2-3 years, commencement of revenue/token circulation
10/22/2027Token Name = JMK Token
Token Symbol = JMK
Stage of Phase = Second Stage (Running)
Price = 1 USD (1 JMK = 1 USD)
Start Date = 10/19/2025
End Date = 05/20/2026
Min Amount = 500 JMK
Max Amount = 9,630,000,000 JMK
Soft Cap = 2,905,277,961 JMK
Hard Cap = 10,258,393,883 JMK
Total Token = 10,258,393,883JMK
Raised Token = 2,905,277,961 JMK (28%)
Each member of our multidisciplinary team plays a vital role—from our medical researchers pioneering breakthrough cell therapies to our technology specialists ensuring transparency and efficiency.
At JMK Stemcell, we are driven by a shared vision—to redefine regenerative medicine through science, innovation, and integrity. Our team brings together world-class experts in biotechnology, clinical research, and blockchain innovation, united by a mission to make advanced stem cell therapy accessible and secure.
CEO/Manager
Senior Biomedical Doctor
Biomedical Surgeon
Software Engineer
Blockchain Expert
Crypto Analyst
Investor/Partner
Investor/Partner
Professional Marketer
Some investors that have been with us through the process, see what they say about us!
Investing in JMK Stemcell Token has given me hope that finance can actually empower breakthroughs in medicine. Watching this project grow makes me believe my investment can help change lives, not just my portfolio.
It’s refreshing to see a team so open, honest, and driven. Supporting JMK Stemcell Token isn’t just business for me—it’s believing in better healthcare for everyone, and that means a lot to me personally.
Being a biomedical researcher, I’ve always dreamed of seeing science and technology truly work together for good. JMK Stemcell Token feels like that dream finally coming to life, and I’m proud to be part of it.